Table 1.
Treatment pattern | N (%) |
---|---|
All patients | 126,188 (100) |
No OP treatment within 1 year of OP diagnosis | 91,021 (72.1) |
First OP treatment within 1 year of OP diagnosis | |
Bisphosphonate | 27,267 (21.6) |
Alendronate | 15,194 (12.0) |
Ibandronate | 4,702 (3.7) |
Risedronate | 6,144 (4.9) |
Zoledronic acid | 1,227 (1.0) |
Nonbisphosphonate | 7,900 (6.3) |
Calcitonin | 5,438 (4.3) |
Raloxifene | 1,317 (1.0) |
Teriparatide | 1,145 (0.9) |
Average time from OP diagnosis to treatment initiation, days | Mean (SD) |
Any treatment (N=35,167) | 75.4 (88.9) |
Bisphosphonate (N=27,267) | 79.4 (91.8) |
Nonbisphosphonate (N=7,900) | 61.6 (76.3) |
Abbreviations: OP, osteoporosis; SD, standard deviation; N, total number.